Pdf Ment and Disease Emergence in Humans and Wildlife

Total Page:16

File Type:pdf, Size:1020Kb

Pdf Ment and Disease Emergence in Humans and Wildlife Peer-Reviewed Journal Tracking and Analyzing Disease Trends pages 853-1040 EDITOR-IN-CHIEF D. Peter Drotman Managing Senior Editor EDITORIAL BOARD Polyxeni Potter, Atlanta, Georgia, USA Dennis Alexander, Addlestone, Surrey, UK Associate Editors Timothy Barrett, Atlanta, Georgia, USA Paul Arguin, Atlanta, Georgia, USA Barry J. Beaty, Ft. Collins, Colorado, USA Charles Ben Beard, Ft. Collins, Colorado, USA Martin J. Blaser, New York, New York, USA Ermias Belay, Atlanta, Georgia, USA Christopher Braden, Atlanta, Georgia, USA David Bell, Atlanta, Georgia, USA Arturo Casadevall, New York, New York, USA Sharon Bloom, Atlanta, GA, USA Kenneth C. Castro, Atlanta, Georgia, USA Mary Brandt, Atlanta, Georgia, USA Louisa Chapman, Atlanta, Georgia, USA Corrie Brown, Athens, Georgia, USA Thomas Cleary, Houston, Texas, USA Charles H. Calisher, Ft. Collins, Colorado, USA Vincent Deubel, Shanghai, China Michel Drancourt, Marseille, France Ed Eitzen, Washington, DC, USA Paul V. Effler, Perth, Australia Daniel Feikin, Baltimore, Maryland, USA David Freedman, Birmingham, Alabama, USA Anthony Fiore, Atlanta, Georgia, USA Peter Gerner-Smidt, Atlanta, Georgia, USA Kathleen Gensheimer, Cambridge, Massachusetts, USA Stephen Hadler, Atlanta, Georgia, USA Duane J. Gubler, Singapore Nina Marano, Atlanta, Georgia, USA Richard L. Guerrant, Charlottesville, Virginia, USA Martin I. Meltzer, Atlanta, Georgia, USA Scott Halstead, Arlington, Virginia, USA David Morens, Bethesda, Maryland, USA Katrina Hedberg, Portland, Oregon, USA J. Glenn Morris, Gainesville, Florida, USA David L. Heymann, London, UK Patrice Nordmann, Paris, France Charles King, Cleveland, Ohio, USA Tanja Popovic, Atlanta, Georgia, USA Keith Klugman, Seattle, Washington, USA Didier Raoult, Marseille, France Takeshi Kurata, Tokyo, Japan Pierre Rollin, Atlanta, Georgia, USA S.K. Lam, Kuala Lumpur, Malaysia Ronald M. Rosenberg, Fort Collins, Colorado, USA Stuart Levy, Boston, Massachusetts, USA Dixie E. Snider, Atlanta, Georgia, USA John S. MacKenzie, Perth, Australia Frank Sorvillo, Los Angeles, California, USA Marian McDonald, Atlanta, Georgia, USA David Walker, Galveston, Texas, USA John E. McGowan, Jr., Atlanta, Georgia, USA J. Todd Weber, Atlanta, Georgia, USA Tom Marrie, Halifax, Nova Scotia, Canada Philip P. Mortimer, London, UK Founding Editor Joseph E. McDade, Rome, Georgia, USA Fred A. Murphy, Galveston, Texas, USA Barbara E. Murray, Houston, Texas, USA Senior Associate Editor, Emeritus P. Keith Murray, Geelong, Australia Brian W.J. Mahy, Bury St. Edmunds, Suffolk, UK Stephen M. Ostroff, Harrisburg, Pennsylvania, USA Copy Editors Claudia Chesley, Karen Foster, Thomas Gryczan, Richard Platt, Boston, Massachusetts, USA Jean Michaels Jones, Shannon O’Connor, Carol Snarey, Gabriel Rabinovich, Buenos Aires, Argentina P. Lynne Stockton Mario Raviglione, Geneva, Switzerland David Relman, Palo Alto, California, USA Production Alicia Scarborough, Barbara Segal, Reginald Tucker Connie Schmaljohn, Frederick, Maryland, USA Editorial Assistant Tracey Hodges Tom Schwan, Hamilton, Montana, USA Communications/Social Media Sarah Logan Gregory Ira Schwartz, Valhalla, New York, USA Tom Shinnick, Atlanta, Georgia, USA Emerging Infectious Diseases is published monthly by the Centers for Disease Bonnie Smoak, Bethesda, Maryland, USA Control and Prevention, 1600 Clifton Road, Mailstop D61, Atlanta, GA 30333, Rosemary Soave, New York, New York, USA USA. Telephone 404-639-1960, fax 404-639-1954, email [email protected]. P. Frederick Sparling, Chapel Hill, North Carolina, USA The opinions expressed by authors contributing to this journal do not neces- Robert Swanepoel, Pretoria, South Africa sarily reflect the opinions of the Centers for Disease Control and Prevention or Phillip Tarr, St. Louis, Missouri, USA the institutions with which the authors are affiliated. Timothy Tucker, Cape Town, South Africa All material published in Emerging Infectious Diseases is in the public do- Elaine Tuomanen, Memphis, Tennessee, USA main and may be used and reprinted without special permission; proper citation, however, is required. John Ward, Atlanta, Georgia, USA Use of trade names is for identification only and does not imply endorsement Mary E. Wilson, Cambridge, Massachusetts, USA by the Public Health Service or by the U.S. Department of Health and Human Services. ∞ Emerging Infectious Diseases is printed on acid-free paper that meets the requirements of ANSI/NISO 239.48-1992 (Permanence of Paper) Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 19, No. 6, June 2013 June 2013 On the Cover Pandemic Influenza Planning, United States, 1978–2008................... 879 James Barsness J. Iskander et al. (b. 1954) My Valley (2003–2005) Benefits from pandemic planning preparedness Acrylic, ink on paper mounted will enhance our collective public health on canvas (125.7 cm x 171.5 cm) response to the next infectious disease crisis. Copyright courtesy of the artist and Cell Culture and Electron Microscopy George Adams Gallery, New York for Identifying Viruses in Diseases of About the Cover p. 1036 Unknown Cause .................................. 886 C.S. Goldsmith et al. Perspectives Rapid identification of causative agents of viral diseases is imperative. Prospects for Emerging Infections in East and Southeast Asia 10 Years after SARS ........................................... 853 P.W. Horby et al. Capacities for predicting, identifying, and Iatrogenic Blood-borne controlling biological threats must not stagnate. Viral Infections in Refugee Public Health Lessons from Children from War and SARS a Decade Later ......................... 861 Transition Zones ................. 892 J.P. Koplan et al. P.N. Goldwater Incidence is unknown because modes of National public health institutes have long-term transmission of individual cases is difficult value during disease outbreaks. to document. p. 855 Synopses Zoonotic Mycobacterium bovis–induced Tuberculosis in Humans .................... 899 Progress in Global Surveillance B. Müller et al. and Response Capacity 10 Years A systematic review suggests worldwide low after SARS ........................................... 864 incidence but reveals elevated effects among C.R. Braden et al. some populations. Global surveillance and response capacity has improved, but important gaps persist, Research and microbial threats remain. p. 948 Group A Streptococcus Strains New Delhi Metallo-β-Lactamase– Circulating during Scarlet Fever producing Enterobacteriaceae, Epidemic, Beijing, China, 2011 .......... 909 United States....................................... 870 P. Yang et al. J.K. Rasheed et al. Wider surveillance is warranted to monitor Isolates comprise a diversity of bacterial possible spread of the predominant strain type, species, plasmid types, and NDM alleles. emm12, to other countries. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 19, No. 6, June 2013 Transmission Potential of Rift Valley Fever Virus over Course of the 2010 Epidemic in South Africa ................... 916 June 2013 R. Métras et al. Novel Mycobacterium tuberculosis Epidemic fade-out occurred as susceptible Complex Isolate from a Wild hosts were depleted and vector-suitable Chimpanzee ........................................ 969 environmental conditions declined. M. Coscolla et al. Effect of Travel on Influenza New strains could emerge as a result of Epidemiology ...................................... 925 proximity between humans and wildlife. S.-M. Belderok et al. Short-term travel to tropical and subtropical Dispatches areas probably contributes to spread worldwide. 977 Endemic Norovirus Infections Haemophilus influenzaeSerotype in Children, Ho Chi Minh City, a Invasive Disease, Alaska, Vietnam, 2009–2010 1983–2011 ............................................ 932 P.V. Tra My et al. M.G. Bruce et al. Highest rates of this invasive disease in Alaska p. 956 981 Human Melioidosis, Malawi, 2011 were among Alaska Native children. T. Katangwe et al. Effect of Winter School Breaks on 985 BSE-associated Prion-Amyloid Influenza-like Illness, Argentina, Cardiomyopathy in Primates 2005–2008............................................ 938 S. Krasemann et al. R.C. Garza et al. Two-week breaks significantly reduced illness 989 Novel SARS-like among children and adults. Betacoronaviruses in Bats, China, 2011 Spatiotemporal Dynamics of Dengue L. Yang et al. Epidemics, Southern Vietnam ........... 945 H.Q. Cuong et al. p. 986 992 Human Papillomavirus Genital Control efforts could be limited to areas where Infections among Men, incidence is high and dry seasons are common. China, 2007–2009 Z. He et al. Active Surveillance for Influenza A Virus among Swine, Midwestern 996 Treatment of Tularemia in United States, 2009–2011 ................... 954 Pregnant Woman, France C.A. Corzo et al. C. Dentan et al. Different influenza viruses circulate simultaneously among pig populations 999 Ciprofloxacin-Resistant throughout the year. Salmonella enterica Serovar Kentucky in Canada M.R. Mulvey et al. 1002 Novel Poxvirus in Big Brown Foodborne Botulism Bats, Northwestern in Canada, 1985–2005 ........ 961 United States D. Leclair et al. G.L. Emerson et al. Improvements in case identification and early treatment have led to a substantial 1005 Fatal Influenza decrease in case-fatality rates. A(H1N1)pdm09 Encephalopathy in Immunocompetent Man M. Simon et al. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 19, No. 6, June 2013 1023 Flaviviruses in Game Birds, Southern Spain, 2011–2012 June 2013 1025 Absence of Rift Valley Fever Letters
Recommended publications
  • An Update Review of Globally Reported SARS-Cov-2 Vaccines in Preclinical and Clinical Stages
    International Immunopharmacology 96 (2021) 107763 Contents lists available at ScienceDirect International Immunopharmacology journal homepage: www.elsevier.com/locate/intimp Review An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages Hamid Motamedi a, Marzie Mahdizade Ari b, Shirin Dashtbin b, Matin Fathollahi a, Hadi Hossainpour a, Amirhoushang Alvandi a,c, Jale Moradi a, Ramin Abiri a,d,* a Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran b Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran c Medical Technology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran d Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran ARTICLE INFO ABSTRACT Keywords: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the rapidly spreading COVID-19 pandemic COVID-19 in the world. As an effective therapeutic strategy is not introduced yet and the rapid genetic SARS-CoV-2 variations in the virus, there is an emerging necessity to design, evaluate and apply effective new vaccines. An Vaccines acceptable vaccine must elicit both humoral and cellular immune responses, must have the least side effects and the storage and transport systems should be available and affordable for all countries. These vaccines can be classified into different types: inactivated vaccines, live-attenuated virus vaccines, subunit vaccines, virus-like particles (VLPs), nucleic acid-based vaccines (DNA and RNA) and recombinant vector-based vaccines (repli­ cating and non-replicating viral vector). According to the latest update of the WHO report on April 2nd, 2021, at least 85 vaccine candidates were being studied in clinical trial phases and 184 candidate vaccines were being evaluated in pre-clinical stages.
    [Show full text]
  • SARS Epidemic in the Press
    LETTERS SARS Epidemic in these peaks were identified by deter- on airport measures, increased quar- mining the most frequently covered antine measures in China, and the the Press topics, specifically: the death of Carlo identification of the civet cat as a To the Editor: On March 12 2003, Urbani, the Italian WHO officer who probable source of SARS-CoV. the World Health Organization identified the disease in Hanoi; the Coverage tended to be greater on (WHO) issued a global alert regarding first two probable cases in Italy; the weekends, probably because political severe acute respiratory syndrome death of a suspected case in Naples; stories constitute less competition for (SARS) in Vietnam, Hong Kong, and and the press conference announcing space on these days. China’s Guangdong Province. Three the first meeting of the Italian Evidently, the daily newspaper days later, for the first time in its his- National Task Force. The highest peak coverage of SARS has been quite tory, WHO recommended postponing occurred on April 23, after the extensive in Italy, especially in the nonessential travel to the affected announcement that the number of aftermath of WHO alerts and state- areas and screening airline passengers cases had reached 4,000 and that a ments by the Ministry of Health (1). These initiatives, together with vaccine would not be available any- regarding new cases and more strin- the awareness of the modes transmis- time soon. In the days after the peak, gent control measures. During out- sion of the coronavirus associated coverage remained quite high, in breaks of infections, both the media with SARS (SARS-CoV), led to association with the definition of and the public are often criticized for extensive press coverage.
    [Show full text]
  • Computational Pan-Genomics: Status, Promises and Challenges
    bioRxiv preprint doi: https://doi.org/10.1101/043430; this version posted March 12, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Computational Pan-Genomics: Status, Promises and Challenges Tobias Marschall1,2, Manja Marz3,60,61,62, Thomas Abeel49, Louis Dijkstra6,7, Bas E. Dutilh8,9,10, Ali Ghaffaari1,2, Paul Kersey11, Wigard P. Kloosterman12, Veli M¨akinen13, Adam Novak15, Benedict Paten15, David Porubsky16, Eric Rivals17,63, Can Alkan18, Jasmijn Baaijens5, Paul I. W. De Bakker12, Valentina Boeva19,64,65,66, Francesca Chiaromonte20, Rayan Chikhi21, Francesca D. Ciccarelli22, Robin Cijvat23, Erwin Datema24,25,26, Cornelia M. Van Duijn27, Evan E. Eichler28, Corinna Ernst29, Eleazar Eskin30,31, Erik Garrison32, Mohammed El-Kebir5,33,34, Gunnar W. Klau5, Jan O. Korbel11,35, Eric-Wubbo Lameijer36, Benjamin Langmead37, Marcel Martin59, Paul Medvedev38,39,40, John C. Mu41, Pieter Neerincx36, Klaasjan Ouwens42,67, Pierre Peterlongo43, Nadia Pisanti44,45, Sven Rahmann29, Ben Raphael46,47, Knut Reinert48, Dick de Ridder50, Jeroen de Ridder49, Matthias Schlesner51, Ole Schulz-Trieglaff52, Ashley Sanders53, Siavash Sheikhizadeh50, Carl Shneider54, Sandra Smit50, Daniel Valenzuela13, Jiayin Wang70,71,72, Lodewyk Wessels56, Ying Zhang23,5, Victor Guryev16,12, Fabio Vandin57,34, Kai Ye68,69,72 and Alexander Sch¨onhuth5 1Center for Bioinformatics, Saarland University, Saarbr¨ucken, Germany; 2Max Planck Institute for Informatics, Saarbr¨ucken,
    [Show full text]
  • Serratia Marcescens: Outer Membrane Porins and Comparative Genomics
    Serratia marcescens: Outer Membrane Porins and Comparative Genomics By Alexander Diamandas A Thesis submitted to the Faculty of Graduate Studies of The University of Manitoba In partial fulfillment of the requirements of the degree of Master of Science Department of Microbiology University of Manitoba Winnipeg Copyright © 2019 by Alexander Diamandas Table of Contents Abstract ........................................................................................................................................................ v Acknowledgments ...................................................................................................................................... vi List of Tables .............................................................................................................................................. vii List of Figures ............................................................................................................................................ viii 1. Literature Review: ............................................................................................................................ 10 1.1. Serratia marcescens .................................................................................................................... 10 1.1.1. Species ................................................................................................................................ 11 1.1.2. Incidence and Mortality .....................................................................................................
    [Show full text]
  • CURRICULUM VITAE George M. Weinstock, Ph.D
    CURRICULUM VITAE George M. Weinstock, Ph.D. DATE September 26, 2014 BIRTHDATE February 6, 1949 CITIZENSHIP USA ADDRESS The Jackson Laboratory for Genomic Medicine 10 Discovery Drive Farmington, CT 06032 [email protected] phone: 860-837-2420 PRESENT POSITION Associate Director for Microbial Genomics Professor Jackson Laboratory for Genomic Medicine UNDERGRADUATE 1966-1967 Washington University EDUCATION 1967-1970 University of Michigan 1970 B.S. (with distinction) Biophysics, Univ. Mich. GRADUATE 1970-1977 PHS Predoctoral Trainee, Dept. Biology, EDUCATION Mass. Institute of Technology, Cambridge, MA 1977 Ph.D., Advisor: David Botstein Thesis title: Genetic and physical studies of bacteriophage P22 genomes containing translocatable drug resistance elements. POSTDOCTORAL 1977-1980 Postdoctoral Fellow, Department of Biochemistry TRAINING Stanford University Medical School, Stanford, CA. Advisor: Dr. I. Robert Lehman. ACADEMIC POSITIONS/EMPLOYMENT/EXPERIENCE 1980-1981 Staff Scientist, Molec. Gen. Section, NCI-Frederick Cancer Research Facility, Frederick, MD 1981-1983 Staff Scientist, Laboratory of Genetics and Recombinant DNA, NCI-Frederick Cancer Research Facility, Frederick, MD 1981-1984 Adjunct Associate Professor, Department of Biological Sciences, University of Maryland, Baltimore County, Catonsville, MD 1983-1984 Senior Scientist and Head, DNA Metabolism Section, Lab. Genetics and Recombinant DNA, NCI-Frederick Cancer Research Facility, Frederick, MD 1984-1990 Associate Professor with tenure (1985) Department of Biochemistry
    [Show full text]
  • (Sars) and Other Outbreak-Prone Diseases
    REPORT OF THE REGIONAL COMMITTEE 17 (4) to collaborate with Member States and partners to monitor the TB control programme, including conducting joint programme reviews; (5) to support Member States to respond more effectively to the impact of poverty and marginalization on TB control; (6) to support Member States to develop better estimations of TB incidence by using all available data and improving estimation methods and in so doing to enable a more accurate assessment of the case detection rate; (7) to support Member States to improve surveillance for and management of TBIHIV and multi drug-resistant TB; (8) to ensure that the recommendations of the external evaluation team are carried out. Ninth meeting, 12 September 2003 WPRlRC54/SRJ9 WPRlRC54.R7 SEVERE ACUTE RESPIRATORY SYNDROME (SARS) AND OTHER OUTBREAK-PRONE DISEASES The Regional Committee, Recalling resolution WHA56.29 on severe acute respiratory syndrome (SARS) and WHA56.28 on the revision of the International Health Regulations; Recognizing the dedication and courage of the health workers of the Western Pacific Region in responding to SARS outbreaks; Further recognizing the health workers who lost their lives combating the disease and WHO staff member Dr Carlo Urbani, who in late February 2003 first brought SARS to the attention of the international community and died ofSARS on 29 March 2003; Acknowledging that strong government commitment, excellent collaboration between Member States and the international community, and rapid mobilization of human and financial resources
    [Show full text]
  • Governance and the HIV/AIDS Epidemic in Vietnam by Alfred John
    Governance and the HIV/AIDS Epidemic in Vietnam by Alfred John Montoya A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Anthropology in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Aihwa Ong, Chair Professor Paul Rabinow Professor Peter Zinoman Spring 2010 Governance and the HIV/AIDS Epidemic in Vietnam © 2010 By Alfred John Montoya For Michael A. Montoya, Elizabeth Alonzo, and Mary Theresa Alonzo. i Acknowledgements First, I‘d like to express my endless gratitude to my family, always with me, in far-flung places. To them I owe more than I can say. This work would not have been possible without the warm mentorship and strong support of my excellent advisors, Aihwa Ong, Paul Rabinow and Peter Zinoman. Their guidance and encouragement made all the difference. I would also like to acknowledge the intellectual and personal generosity of David Spener, Alan Pred, and Nancy Scheper-Hughes who contributed so much to my training and growth. Additionally, this work and I benefitted greatly from the myriad commentators and co-laborers from seminars, conference panels and writing groups. I would specifically like to extend my gratitude to those from the Fall 2004 graduate student cohort in the Department of Anthropology at UC Berkeley, particularly Amelia Moore and Shana Harris, whose friendship and company made graduate school and graduate student life a pleasure. Also, my heartfelt thanks to Emily Carpenter, my friend, through the triumphs and travails of these six years and this project that consumed them. Many thanks to the participants in the Anthropology of the Contemporary Research Collaboratory, at UC Berkeley.
    [Show full text]
  • Air China Limited
    Air China Limited Air China Limited Stock code: 00753 Hong Kong 601111 Shanghai AIRC London Annual Report 20 No. 30, Tianzhu Road, Airport Industrial Zone, Shunyi District, Beijing, 101312, P.R. China Tel 86-10-61462560 Fax 86-10-61462805 19 Annual Report 2019 www.airchina.com.cn 中國國際航空股份有限公司 (short name: 中國國航) (English name: travel experience and help passengers to stay safe by upholding the Air China Limited, short name: Air China) is the only national spirit of phoenix of being a practitioner, promoter and leader for the flag carrier of China. development of the Chinese civil aviation industry. The Company is also committed to leading the industrial development by establishing As the old saying goes, “Phoenix, a bird symbolizing benevolence” itself as a “National Brand”, at the same time pursuing outstanding and “The whole world will be at peace once a phoenix reveals performance through innovative and excelling efforts. itself”. The corporate logo of Air China is composed of an artistic phoenix figure, the Chinese characters of “中國國際航空公司” in Air China was listed on The Stock Exchange of Hong Kong Limited calligraphy written by Mr. Deng Xiaoping, by whom the China’s (stock code: 0753) and the London Stock Exchange (stock code: reform and opening-up blueprint was designed, and the characters of AIRC) on 15 December 2004, and was listed on the Shanghai Stock “AIR CHINA” in English. Signifying good auspices in the ancient Exchange (stock code: 601111) on 18 August 2006. Chinese legends, phoenix is the king of all birds. It “flies from the eastern Happy Land and travels over mountains and seas and Headquartered in Beijing, Air China has set up branches in Southwest bestows luck and happiness upon all parts of the world”.
    [Show full text]
  • Combating the Coronavirus Pandemic Early Detection, Medical Treatment
    AAAS Research Volume 2020, Article ID 6925296, 35 pages https://doi.org/10.34133/2020/6925296 Review Article Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community Zichao Luo,1 Melgious Jin Yan Ang,1,2 Siew Yin Chan,3 Zhigao Yi,1 Yi Yiing Goh,1,2 Shuangqian Yan,1 Jun Tao,4 Kai Liu,5 Xiaosong Li,6 Hongjie Zhang ,5,7 Wei Huang ,3,8 and Xiaogang Liu 1,9,10 1Department of Chemistry, National University of Singapore, Singapore 117543, Singapore 2NUS Graduate School for Integrative Sciences and Engineering, Singapore 117456, Singapore 3Frontiers Science Center for Flexible Electronics & Shaanxi Institute of Flexible Electronics, Northwestern Polytechnical University, Xi’an 710072, China 4Sports Medical Centre, The Second Affiliated Hospital of Nanchang University, Nanchang 330000, China 5State Key Laboratory of Rare Earth Resource Utilization, Chang Chun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China 6Department of Oncology, The Fourth Medical Center of Chinese People’s Liberation Army General Hospital, Beijing 100048, China 7Department of Chemistry, Tsinghua University, Beijing 100084, China 8Key Laboratory of Flexible Electronics & Institute of Advanced Materials, Nanjing Tech University, Nanjing 211816, China 9The N.1 Institute for Health, National University of Singapore, Singapore 10Joint School of National University of Singapore and Tianjin University, International Campus of Tianjin University, Fuzhou 350807, China Correspondence should be addressed to Hongjie Zhang; [email protected], Wei Huang; [email protected], and Xiaogang Liu; [email protected] Received 19 April 2020; Accepted 20 April 2020; Published 16 June 2020 Copyright © 2020 Zichao Luo et al.
    [Show full text]
  • Pandemic.Pdf.Pdf
    1 PANDEMICS: Past, Present, Future Published in 2021 by the Mahatma Gandhi Institute of Education for Peace and Challenges & Opportunities Sustainable Development, 35 Ferozshah Road, New Delhi 110001, India © UNESCO MGIEP This publication is available in Open Access under the Attribution-ShareAlike Coordinating Lead Authors: 3.0 IGO (CC-BY-SA 3.0 IGO) license (http://creativecommons.org/licenses/ ANANTHA KUMAR DURAIAPPAH by-sa/3.0/ igo/). By using the content of this publication, the users accept to be Director, UNESCO MGIEP bound by the terms of use of the UNESCO Open Access Repository (http:// www.unesco.org/openaccess/terms-use-ccbysa-en). KRITI SINGH Research Officer, UNESCO MGIEP The designations employed and the presentation of material throughout this publication do not imply the expression of any opinion whatsoever on the part of UNESCO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The ideas and opinions expressed in this publication are those of the authors; they Lead Authors: NANDINI CHATTERJEE SINGH are not necessarily those of UNESCO and do not commit the Organization. Senior Programme Officer, UNESCO MGIEP The publication can be cited as: Duraiappah, A. K., Singh, K., Mochizuki, Y. YOKO MOCHIZUKI (Eds.) (2021). Pandemics: Past, Present and Future Challenges and Opportunities. Head of Policy, UNESCO MGIEP New Delhi. UNESCO MGIEP. SHAHID JAMEEL Coordinating Lead Authors: Director, Trivedi School of Biosciences, Ashoka University Anantha Kumar Duraiappah, Director, UNESCO MGIEP Kriti Singh, Research Officer, UNESCO MGIEP Lead Authors: Nandini Chatterjee Singh, Senior Programme Officer, UNESCO MGIEP Contributing Authors: CHARLES PERRINGS Yoko Mochizuki, Head of Policy, UNESCO MGIEP Global Institute of Sustainability, Arizona State University Shahid Jameel, Director, Trivedi School of Biosciences, Ashoka University W.
    [Show full text]
  • Brief History of the Global SARS Outbreak of 2002–03
    5 Brief History of the Global SARS Outbreak of 2002–03 An epidemic unfolds before the global society Severe Acute Respiratory Syndrome (SARS) was the first severe infectious disease to emerge in the twenty-first century. SARS was also a global epi- demic that unfolded with an unprecedented amount of global atten- tion. Even with the war in Iraq taking place during the early phases of the global response, SARS gained significant press and media coverage for weeks. The global community witnessed a world-wide health threat unfold and could watch and follow closely how national and inter- national public health authorities grappled with the outbreak. The surgi- cal mask, worn by citizens of SARS-affected areas, became a global symbol of the threat and the fear that SARS triggered. This chapter does not attempt a comprehensive history of the SARS outbreak, because such an undertaking would itself produce a book. Rather, this chapter provides a brief narrative history of the SARS out- break to highlight the key moments, episodes, and developments. My objective is to give the reader a general sense of what happened during the outbreak. This sense will help the reader follow the arguments in Chapters 6–8 more effectively. Sometime before November 2002: Animal to human, Guangdong Province? The question on many minds, not least the epidemiologists and public health experts struggling to contain SARS, was: From where did SARS come? Over the course of the outbreak, epidemiological guesses about SARS’ origin were made. Although, at the time of this writing, none of the guesses had been definitively proved, the leading hypothesis is that 71 D.
    [Show full text]
  • COVIPENDIUM Aug4.Pdf
    COVIPENDIUM Information available to support the development of medical countermeasures and interventions against COVID-19 Cite as: Martine DENIS, Valerie VANDEWEERD, Rein VERBEEKE, Anne LAUDISOIT, Tristan REID, Emma HOBBS, Laure WYNANTS & Diane VAN DER VLIET. (2020). COVIPENDIUM: information available to support the development of medical countermeasures and interventions against COVID-19 (Version 2020-08-04). Transdisciplinary Insights. This document is conceived as a living document, updated on a weekly basis. You can find its latest version at: https://rega.kuleuven.be/if/corona_covid-19. The COVIPENDIUM is based on open-access publications (scientific journals and preprint databases, communications by WHO and OIE, health authorities and companies) in English language. Please note that the present version has not been submitted to any peer-review process. Any comment / addition that can help improve the contents of this review will be most welcome. For navigation through the various sections, please click on the headings of the table of contents and follow the links marked in blue in the document. Authors: Martine Denis, Valerie Vandeweerd, Rein Verbeke, Anne Laudisoit, Tristan Reid, Emma Hobbs, Laure Wynants, Diane Van der Vliet COVIPENDIUM version: 04 AUG 2020 Transdisciplinary Insights - Living Paper | 1 Contents List of abbreviations .......................................................................................................................................................... 9 Introduction ...................................................................................................................................................................
    [Show full text]